In this work we showed that in vitro VSSP treatment of both tumor-induced MDSCs and BM-MDSCs was sufficient to increase not only CD11c marker, typically associated with DCs, but also the co-stimulatory molecules CD40 and CD86. This evidence concerns the gene CD86 and neoplasm.